Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer.

MLA

Redman, Jason M., et al. “Enhanced Neoepitope-Specific Immunity Following Neoadjuvant PD-L1 and TGF-β Blockade in HPV-Unrelated Head and Neck Cancer.” The Journal of Clinical Investigation, vol. 132, no. 18, Sept. 2022. EBSCOhost, https://doi.org/10.1172/JCI161400.

APA

Redman, J. M., Friedman, J., Robbins, Y., Sievers, C., Yang, X., Lassoued, W., Sinkoe, A., Papanicolau-Sengos, A., Lee, C.-C., Marte, J. L., Turkbey, E., Mydlarz, W., Joshi, A., London, N. R., Jr, Pierce, M., Taylor, R., Hong, S., Nguyen, A., Soon-Shiong, P., … Allen, C. T. (2022). Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer. The Journal of Clinical Investigation, 132(18). https://doi.org/10.1172/JCI161400

Chicago

Redman, Jason M, Jay Friedman, Yvette Robbins, Cem Sievers, Xinping Yang, Wiem Lassoued, Andrew Sinkoe, et al. 2022. “Enhanced Neoepitope-Specific Immunity Following Neoadjuvant PD-L1 and TGF-β Blockade in HPV-Unrelated Head and Neck Cancer.” The Journal of Clinical Investigation 132 (18). doi:10.1172/JCI161400.